The Latest Research

Filter by

showing 181 of 366

July 20, 2015

MS Society-funded researchers find that anxiety, but not depression, is linked to gender in multiple sclerosis

July 9, 2015

Researchers describe a small molecule involved in remyelination that could help distinguish between disease stages and predict disability

June 26, 2015

MS Society-funded study investigates running as a possible therapeutic strategy to reduce MS-related pain

June 11, 2015

MS-Society funded postdoctoral fellow identifies promising new biomarkers for secondary progressive MS

June 8, 2015

Rebif® (interferon beta-1a) continues to demonstrates efficacy in treating clinically isolated syndrome and reducing conversion to MS

June 5, 2015

MS Society-funded research uncovers new mechanism by which front-line MS therapeutic interferon-beta suppresses harmful inflammation

May 28, 2015

MS Society-funded research uncovers a promising new therapeutic target for preventing immune cell invasion of the brain

May 27, 2015

MS Society-funded study brings to light importance of treating other medical conditions to improve health and survival

May 27, 2015

Two drugs used to treat non-MS conditions promote myelin repair in mice

May 25, 2015

2015 MS Research Town Hall

May 14, 2015

MS Society-funded fellow demonstrates the ability of the hormone prolactin, when combined with interferon-β, to reduce disease severity in animals with MS-like disease.

May 1, 2015

Researchers link the complement system, an integral part of the body’s immune network, to multiple sclerosis disease progression

April 14, 2015

Researchers identify new potential genetic risk factor for relapsing-remitting MS in women

April 7, 2015

MSSRF-funded study demonstrates that proper myelin repair depends on the removal of myelin debris by specialized immune cells

March 30, 2015

Cell-based study reveals that vitamin D can drive the activity of neural stem cells that promote myelin repair

March 24, 2015

Exercise may improve cognitive performance in people with relapsing-remitting multiple sclerosis

March 13, 2015

Infection with Helicobacter pylori may protect against multiple sclerosis risk in women

March 6, 2015

MS Society-funded fellow publishes study that examines new class of compounds with the potential to protect against nerve damage and halt MS progression

March 3, 2015

MS Society-funded study puts to test a promising new target for MS treatment that has significant potential to stop neurodegeneration and promote recovery

February 19, 2015

Case of PML reported in patient treated with Gilenya®

Interested in the national Quebec e-newsletter? Join our waitlist.

In Quebec, e-newsletters are created at the chapter level. Quebec residents can contact their local chapter and request to be added to their specific e-newsletter subscriber list.
Click here to view our Quebec chapters

About Multiple Sclerosis (MS)

Managing Multiple Sclerosis

Multiple Sclerosis Support

Leading MS Research

Join our efforts against MS

About MS Canada

About Multiple Sclerosis (MS)

Managing Multiple Sclerosis

Menu Find Support

Multiple Sclerosis Support

Leading MS Research

Join our efforts against MS

About MS Canada

The Latest Research

MS Society-funded researchers find that anxiety, but not depression, is linked to gender in multiple sclerosis

Researchers describe a small molecule involved in remyelination that could help distinguish between disease stages and predict disability

MS Society-funded study investigates running as a possible therapeutic strategy to reduce MS-related pain

MS-Society funded postdoctoral fellow identifies promising new biomarkers for secondary progressive MS

Rebif® (interferon beta-1a) continues to demonstrates efficacy in treating clinically isolated syndrome and reducing conversion to MS

MS Society-funded research uncovers new mechanism by which front-line MS therapeutic interferon-beta suppresses harmful inflammation

MS Society-funded research uncovers a promising new therapeutic target for preventing immune cell invasion of the brain

MS Society-funded study brings to light importance of treating other medical conditions to improve health and survival

Two drugs used to treat non-MS conditions promote myelin repair in mice

2015 MS Research Town Hall

MS Society-funded fellow demonstrates the ability of the hormone prolactin, when combined with interferon-β, to reduce disease severity in animals with MS-like disease.

Researchers link the complement system, an integral part of the body’s immune network, to multiple sclerosis disease progression

Researchers identify new potential genetic risk factor for relapsing-remitting MS in women

MSSRF-funded study demonstrates that proper myelin repair depends on the removal of myelin debris by specialized immune cells

Cell-based study reveals that vitamin D can drive the activity of neural stem cells that promote myelin repair

Exercise may improve cognitive performance in people with relapsing-remitting multiple sclerosis

Infection with Helicobacter pylori may protect against multiple sclerosis risk in women

MS Society-funded fellow publishes study that examines new class of compounds with the potential to protect against nerve damage and halt MS progression

MS Society-funded study puts to test a promising new target for MS treatment that has significant potential to stop neurodegeneration and promote recovery

Case of PML reported in patient treated with Gilenya®

About Multiple Sclerosis (MS)

Managing Multiple Sclerosis

Multiple Sclerosis Support

Leading MS Research

Join our efforts against MS

About MS Canada

About Multiple Sclerosis (MS)

Managing Multiple Sclerosis

Multiple Sclerosis Support

Leading MS Research

Join our efforts against MS

About MS Canada

The Latest Research

MS Society-funded researchers find that anxiety, but not depression, is linked to gender in multiple sclerosis

Researchers describe a small molecule involved in remyelination that could help distinguish between disease stages and predict disability

MS Society-funded study investigates running as a possible therapeutic strategy to reduce MS-related pain

MS-Society funded postdoctoral fellow identifies promising new biomarkers for secondary progressive MS

Rebif® (interferon beta-1a) continues to demonstrates efficacy in treating clinically isolated syndrome and reducing conversion to MS

MS Society-funded research uncovers new mechanism by which front-line MS therapeutic interferon-beta suppresses harmful inflammation

MS Society-funded research uncovers a promising new therapeutic target for preventing immune cell invasion of the brain

MS Society-funded study brings to light importance of treating other medical conditions to improve health and survival

Two drugs used to treat non-MS conditions promote myelin repair in mice

2015 MS Research Town Hall

MS Society-funded fellow demonstrates the ability of the hormone prolactin, when combined with interferon-β, to reduce disease severity in animals with MS-like disease.

Researchers link the complement system, an integral part of the body’s immune network, to multiple sclerosis disease progression

Researchers identify new potential genetic risk factor for relapsing-remitting MS in women

MSSRF-funded study demonstrates that proper myelin repair depends on the removal of myelin debris by specialized immune cells

Cell-based study reveals that vitamin D can drive the activity of neural stem cells that promote myelin repair

Exercise may improve cognitive performance in people with relapsing-remitting multiple sclerosis

Infection with Helicobacter pylori may protect against multiple sclerosis risk in women

MS Society-funded fellow publishes study that examines new class of compounds with the potential to protect against nerve damage and halt MS progression

MS Society-funded study puts to test a promising new target for MS treatment that has significant potential to stop neurodegeneration and promote recovery

Case of PML reported in patient treated with Gilenya®

Sign up for our e-newsletter